Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
about
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialRenal clearance and degradation of glutathione-coated copper nanoparticles[18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery.Layer-by-layer assembled antisense DNA microsponge particles for efficient delivery of cancer therapeutics.Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates.Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.Targeted pharmaceutical nanocarriers for cancer therapy and imagingDAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.Cell adhesion molecules: role and clinical significance in cancer.Lipopeptide delivery of siRNA to the central nervous system.
P2860
Q24657256-585BF324-3E12-4542-91A1-F443E6DA7388Q28829398-CF10C80B-461E-423A-95CE-0E0500042F95Q33755397-ADD6A6C4-A08C-4E40-9A73-3AC23E498D06Q34419904-C8166611-D8D9-435A-8893-B96565596F4DQ35502131-28C1DF5F-9FFD-4D95-9CB7-C08C223DE057Q36695358-36C91C3C-5670-40E1-BA0B-BE40919B4B81Q36871933-78A563AF-B650-45CC-AF6D-7172E3566B23Q37621452-1D59F706-BC9C-4304-8459-BE178F3C8980Q37631589-034C970D-A1FC-475A-BC69-FBF9167872BAQ46250876-509B8E83-27E7-45D9-B561-708823E65855
P2860
Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Biodistribution and pharmacoki ...... or novel targeting strategies.
@ast
Biodistribution and pharmacoki ...... or novel targeting strategies.
@en
type
label
Biodistribution and pharmacoki ...... or novel targeting strategies.
@ast
Biodistribution and pharmacoki ...... or novel targeting strategies.
@en
prefLabel
Biodistribution and pharmacoki ...... or novel targeting strategies.
@ast
Biodistribution and pharmacoki ...... or novel targeting strategies.
@en
P2093
P2860
P356
P1476
Biodistribution and pharmacoki ...... or novel targeting strategies.
@en
P2093
Harrington KJ
Rowlinson-Busza G
Stewart JS
Syrigos KN
P2860
P2888
P304
P356
10.1054/BJOC.1999.1232
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1019774890